Page values for "Tiotropium"
From Pharmacopedia
More actions
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Tiotropium |
| brand | String | Spiriva, Spiriva Respimat |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Antimuscarinics|Antimuscarinic]] • [[:Category:Long-acting_muscarinic_antagonists|Long-acting muscarinic antagonist (LAMA)]] • [[:Category:Bronchodilators|Bronchodilator]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-000009BE-QINU`"', '"`UNIQ--vote-000009BF-QINU`"' |
| starting_dose | String | 18 mcg DPI once daily (HandiHaler); 2.5 mcg per actuation × 2 inhalations once daily (Respimat) |
| preparations | String | 18 mcg HandiHaler capsules; 2.5 mcg/actuation Respimat solution inhaler (1.25 mcg/actuation for asthma indication) |
| fda_max | String | One dose per day |
| pill_id | Text | |
| routes | List of String, delimiter: , | Inhaled (DPI • soft-mist inhaler) |
| onset | String | Bronchodilation 30 minutes; steady-state at 1-2 weeks |
| duration | String | 24 hours (long receptor dissociation half-life from M3) |
| halflife | String | ~25-44 hours plasma; receptor kinetics drive the once-daily duration'"`UNIQ--ref-000009C0-QINU`"' |
| bioavailability | String | Inhaled lung deposition ~20%; systemic absorption from lung ~33%; oral component negligible'"`UNIQ--ref-000009C1-QINU`"' |
| pregnancy | String | Limited data; LABA/LAMA strategies in pregnancy generally favor agents with the most reassuring data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |